AmgenvsCareDx

AMGN and CDNA stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$469.84

Value $253B

+0.90%
AMGN's page

Amgen (AMGN) has a market value of $253B and CareDx (CDNA) $3.9B. Over the last year, with dividends, AMGN moved +43.4% and CDNA +375.6%. The P/E is 27.0 for AMGN and 30.2 for CDNA. Dividend yield: AMGN 2.12%, CDNA none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$253B

    CDNA$3.9B

    AMGN is 65 times CDNA

  • Revenue, 12 months

    AMGN$38.9B

    CDNA$497M

    AMGN is 78 times CDNA

  • Net income, 12 months

    AMGN$9.4B

    CDNA$129M

    AMGN is 73 times CDNA

  • Operating margin

    AMGN32.4%

    CDNA23.4%

    9.0 points apart

  • ROIC

    AMGN16.2%

    CDNA25.3%

    9.1 points apart

  • P/E

    AMGN27.0

    CDNA30.2

    CDNA is 1.1 times AMGN

  • Dividend yield

    AMGN2.1%

    CDNA0.0%

    2.1 points apart

  • 5-year return

    AMGN+162.5%

    CDNA+61.3%

    101.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+162.5%

CDNA+61.3%

010020020222023202420252026
Returns by period
PeriodAMGNWith dividendsCDNAWith dividends
1 year since November 14, 2025+43.4%Price +39.5%+375.6%Price +375.6%
3 years since November 16, 2023+89.6%+23.8% a yearPrice +74.7%+730.3%+102.5% a yearPrice +730.3%
5 years since November 15, 2021+162.5%+21.3% a yearPrice +126.5%+61.3%+10.0% a yearPrice +61.3%
10 years since November 16, 2016+326.9%+15.6% a yearPrice +219.1%+2,163.0%+36.6% a yearPrice +2,163.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenCDNACareDx

Valuation

AMGNCDNA
Valuation
Price$469.84$75.81
Market value$253B$3.9B
Enterprise value (EV)$294B$3.6B
P/E27.030.2
P/E, 5-year median23.0–
P/B17.78.3
EV/EBIT23.331.2
Free cash flow yield3.8%–

Results and growth

AMGNCDNA
Results and growth
Revenue, 12 months$38.9B$497M
Net income, 12 months$9.4B$129M
Free cash flow, 12 months$9.6B–
Earnings per share, 12 months$17.25$2.39
Revenue growth, year on year10.0%13.8%
Revenue growth a year, past+7.6%over 5 years+14.6%over 5 years
EPS growth a year, past+2.9%over 5 years–

Margins and returns on capital

AMGNCDNA
Margins and returns on capital
Gross margin70.9%–
Operating margin32.4%23.4%
Net margin24.1%25.9%
ROIC16.2%25.3%
ROE87.8%35.3%

Balance sheet

AMGNCDNA
Balance sheet
Cash$13.2B$250M
Total debt$54.0B$29M
Net debt / EBITDA2.3-1.9
Interest cover4.8×–

Dividends and buybacks

AMGNCDNA
Dividends and buybacks
Dividend yield2.1%–
Dividend per share, 12 months$9.94–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield–2.3%
Shareholder yield2.1%2.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or CDNA

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or CareDx?

By market value, Amgen ($253B) is about 65.2 times CareDx ($3.9B), at today's prices.

How did AMGN and CDNA stock do over the last 10 years?

Since November 16, 2016, AMGN's price moved +219.1% and CDNA's +2,163.0%. With dividends: AMGN +326.9% (+15.6% a year), CDNA +2,163.0% (+36.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or CDNA?

The dividend yield at today's price is 2.12% for Amgen and none for CareDx. Over the last twelve months they paid $9.94 and – per share.

What is the P/E of AMGN and CDNA?

At today's price, the P/E is 27.0 for AMGN and 30.2 for CDNA. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Amgen or CareDx?

Over the last twelve months, the net margin was 24.1% for Amgen and 25.9% for CareDx, and the operating margin 32.4% and 23.4%. Revenue was $38.9B and $497M.

Which is the better investment, Amgen or CareDx?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.